I'm not sure I'm HAPPY with Booker's vote, but I'm surprised that most of the articles covering this are leaving out that fellow New Jersey Senator and Democrat Bob Menendez ALSO voted against this measure, likely because pharmaceuticals are a major New Jersey industry.
From a NJ State website handout:
Biopharmaceutical Life Sciences Industry Cluster
•New Jersey’s biopharma life sciences cluster employment totaled over 115,000 in 2013, or 3.6 percent of the state’s private sector workers. Nationally, the proportion was just 1.9 percent.
•New Jersey’s biopharmaceutical and life sciences cluster employment is comprised of three primary components: pharmaceutical sector (43.5%), biotechnology (35.4%) and medical device manufacturing (21.1%). In 2013, the state’s pharmaceuticals employment accounted for 8.8 percent of pharmaceuticals jobholding in the U.S.
•Establishments totaled over 3,000 in 2013. Despite recent reorganizations by pharmaceutical firms, the drug and pharmaceutical component’s establishment count increased between 2008 and 2013 by 9.4 percent, outpacing growth nationally (+7.1%) over the same period.
•New Jersey biopharma life science employers paid over $15 billion in wages during 2013, or 7.9 percent of the state’s total wages.
•The state’s highly educated workforce is seen in this cluster as more than three-fifths (62.2%) of its workers statewide hold a Bachelor’s degree or higher: Bachelor’s (29.2%), Master’s/Professional (24.7%), Doctoral (8.3%) degree.
I'm assuming at least some of Booker and Menendez's reasoning is not wanting to screw over their constituents by bringing in pharmaceuticals from another country.
When I see the phrase "the ____ estate", I imagine a vast mansion in the country full of monocled men and high-collared women receiving letters about productions across the country and doing spit-takes at whatever they contain.
-Kad